Health profile of adult special immigrant visa holders arriving from Iraq and Afghanistan to the United States, 2009–2017: A cross-sectional analysis
Autoři:
Gayathri S. Kumar aff001; Simone S. Wien aff001; Christina R. Phares aff001; Walid Slim aff003; Heather M. Burke aff001; Emily S. Jentes aff001
Působiště autorů:
Immigrant, Refugee and Migrant Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
aff001; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, United States of America
aff002; Migration Health Division, International Organization for Migration, Erbil, Iraq
aff003; Migration Health Division, International Organization for Migration, Amman, Jordan
aff004
Vyšlo v časopise:
Health profile of adult special immigrant visa holders arriving from Iraq and Afghanistan to the United States, 2009–2017: A cross-sectional analysis. PLoS Med 17(5): e32767. doi:10.1371/journal.pmed.1003118
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pmed.1003118
Souhrn
Background
Between 2,000 and 19,000 Special Immigrant Visa (SIV) holders (SIVH) from Iraq and Afghanistan resettle in the United States annually. Despite the increase in SIV admissions to the US over recent years, little is known about the health conditions in SIV populations. We assessed the burden of select communicable and noncommunicable diseases (NCDs) in SIV adults to guide recommendations to clinicians in the US.
Methods and findings
We analyzed overseas medical exam data in Centers for Disease Control and Prevention’s (CDC) Electronic Disease Notification system (EDN) for 19,167 SIV Iraqi and Afghan adults who resettled to the US from April 2009 through December 2017 in this cross-sectional analysis. We describe demographic characteristics, tuberculosis screening results, self-reported NCDs, and risk factors for NCDs (such as obesity and tobacco use). In our data set, most SIVH were male (Iraqi: 59.7%; Afghan: 54.7%) and aged 18–44 (Iraqi: 86.3%; Afghan: 95.6%). About 2.3% of Afghan SIVH and 1.1% of Iraqi SIVH had a tuberculosis condition. About 0.3% of all SIVH reported having chronic hepatitis. Among all SIVH, 56.5% were overweight or had obesity, 2.4% reported hypertension, 1.1% reported diabetes, and 19.4% reported current or previous tobacco use. Iraqi SIVH were 3.7 times more likely to have obesity (95% CI: 3.4–4.0), 2.5 times more likely to report diabetes (95% CI: 1.7–3.5), and 2.5 times more likely to be current or former smokers (95% CI: 2.3–2.7) than Afghan SIVH. Limitations include the inability to obtain all SIVH records, self-reported medical history of NCDs, and the underdiagnosis of NCDs such as hypertension and diabetes because formal laboratory testing for NCDs is not used during overseas medical exams.
Conclusion
In this analysis, we found that 56.5% of all SIVH were overweight or had obesity, 2.4% reported hypertension, 1.1% reported diabetes, and 19.4% reported current or previous tobacco use. In general, Iraqi SIVH were more likely to have obesity, diabetes, and be current or former smokers than Afghan SIVH. State public health agencies and clinicians doing domestic screening examinations of SIVH should consider screening for obesity—as per the CDC’s Guidelines for the US Domestic Medical Examination for Newly Arriving Refugees—and smoking and, if appropriate, referral to weight management and smoking cessation services. US clinicians can consider screening for other NCDs at the domestic screening examination. Future studies can explore the health profile of SIV populations, including the prevalence of mental health conditions, after integration into the US.
Klíčová slova:
diabetes mellitus – Health screening – Hypertension – Obesity – Screening guidelines – SIV – Tuberculosis – United States
Zdroje
1. US Department of State, Bureau of Population, Refugees, and Migration. Proposed Refugee Admissions for Fiscal Year 2018. Internet [cited 2018 May 21]. Available from: https://www.state.gov/j/prm/releases/docsforcongress/274613.htm.
2. US Department of State, Bureau of Consular Affairs. Directory of Visa Categories. Internet [cited 2018 May 21]. Available from: https://travel.state.gov/content/travel/en/us-visas/visa-information-resources/all-visa-categories.html.
3. US Department of State, Bureau of Population, Refugees, and Migration. SIV Refugee Benefits Election Form 2017 (English). Internet [cited 2018 May 21]. Available from: https://www.wrapsnet.org/siv-iraqi-syrian-p-2/.
4. US Department of Health and Human Services, Office of the Administration for Children & Families, Office of Refugee Resettlement. Afghan and Iraqi Special Immigrants Are Now Eligible for ORR Benefits and Services to the Same Extent and for the Same Time Periods of Time as Refugees, State Letter #10–02. Internet [cited 2018 May 21]. Available from: https://www.acf.hhs.gov/orr/resource/state-letter-10-02.
5. US Department of Health and Human Services, Office of the Administration for Children & Families, Office of Refugee Resettlement. Health Insurance. Internet [cited 2018 May 21]. Available from: https://www.acf.hhs.gov/orr/health.
6. US Department of Health and Human Services, Office of Refugee Resettlement. Revised Medical Screening Guidelines for Newly Arriving Refugees. Internet [cited 2018 May 21]. Available from: http://www.acf.hhs.gov/sites/default/files/orr/state_letter_12_09_revised_medical_screening_guidelines_for_newly.pdf.
7. US Department of State, Bureau of Population, Refugees, and Migration, Office of Admissions, Refugee Processing Center. Admissions & Arrivals, SIV Arrivals by Nationality by Month. Internet [cited 2018 May 22]. Available from: https://www.wrapsnet.org/admissions-and-arrivals/.
8. US Department of Health and Human Services, Centers for Disease Control and Prevention. Medical Examination of Immigrants and Refugees. Internet [cited 2018 May 21]. Available from: http://www.cdc.gov/immigrantrefugeehealth/exams/medical-examination.html.
9. US Department of Health and Human Services, Centers for Disease Control and Prevention. Technical Instructions for Panel Physicians and Civil Surgeons 2016. Internet [cited 2018 July 10]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/technical-instructions/panel-physicians/medical-history-physical-exam.html.
10. US Department of Health and Human Services, Centers for Disease Control and Prevention. Guidelines for the US Domestic Medical Examination for Newly Arriving Refugees. Internet [cited 2018 May 21]. Available from: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domestic-guidelines.html.
11. Doocy SC, Todd CS, Llainez YB, Ahmadzai A, Burnham GM. Population-based tuberculin skin testing and prevalence of tuberculosis infection in Afghanistan. World Health Popul. 2008;10:44–53. doi: 10.12927/whp.2008.19785 18574343
12. World Health Organization. Afghanistan: Country health profile. Internet [cited 2018 July 29]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=AF&outtype=html.
13. World Health Organization. Iraq: Country health profile. Internet [cited 2018 July 29]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=IQ&outtype=html.
14. US Department of Health and Human Services, Centers for Disease Control and Prevention. Health of resettled Iraqi refugees–San Diego County, California, October 2007–September 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1614–1618. 21160458
15. Yanni EA, Naoum M, Odeh N, Han P, Coleman M, Burke H. The health profile and chronic diseases comorbidities of US-bound Iraqi refugees screened by the International Organization for Migration in Jordan: 2007–2009. J Immigr Minor Health. 2013;15:1–9. doi: 10.1007/s10903-012-9578-6 22307545
16. US Department of Health and Human Services, Centers for Disease Control and Prevention. Tuberculosis Technical Instructions for Panel Physicians. Internet [cited 2019 January 2]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.html.
17. US Department of Health and Human Services, Centers for Disease Control and Prevention. Guidelines for Screening for Tuberculosis Infection and Disease during the Domestic Medical Examination for Newly Arrived Refugees. Internet [cited 2018 July 31]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/tuberculosis-guidelines.html.
18. Pour MS, Kumble S, Hanieh S, Biggs B. Prevalence of dyslipidemia and micronutrient deficiencies among newly arrived Afghan refugees in rural Australia: a cross-sectional study. BMC Public Health. 2014;14:896. doi: 10.1186/1471-2458-14-896 25175525
19. Saeed KM, Rasooly MH, Alkazaj A. Prevalence of risk factors for noncommunicable diseases in Jalalabad City, Afghanistan, evaluated using the WHO STEPwise approach. East Mediterr Health J. 2016;21:783–90. 26857715
20. Jen CKL, Zhou K, Arnetz B, Jamil H. Pre- and post-displacement stressors and body weight development in Iraqi refugees in Michigan. J Immigr Minor Health. 2015;17:1468–1475. doi: 10.1007/s10903-014-0127-3 25376128
21. Mateen FJ, Carone M, Al-Saedy H, Nyce S, Ghosn J, Mutuerandu T, et al. Medical conditions among Iraqi refugees in Jordan: data from the United Nations Refugee Assistance Information System. Bull World Health Organ. 2012; 90:444–451. doi: 10.2471/BLT.11.097048 22690034
22. Kim C, Saeed KM, Salehi AS, Zeng W. An equity analysis of utilization of health services in Afghanistan using a national household survey. BMC Public Health. 2016;16(1):1226. doi: 10.1186/s12889-016-3894-z 27919238
23. Yun K, Fuentes-Afflick E, Desai MM. Prevalence of chronic disease and insurance coverage among refugees in the United States. J Immigrant Minority Health. 2012;14:933–940.
24. Reed HE and Barbosa GY. Investigating the refugee health disadvantage among the US immigrant population. Journal of Immigrant and Refugee Studies. 2017;15(1):53–70.
25. Bennet L, Stenkula K, Cushman SW, Brismar K. BMI and waist circumference cut-offs for corresponding levels of insulin sensitivity in a Middle Eastern immigrant versus a native Swedish population–the MEDIM population based study. BMC Public Health. 2016;16:1242. doi: 10.1186/s12889-016-3892-1 27938404
26. Berkowitz SA, Fabreau GE, Raghavan S, Kentoffio K, Chang Y, He W, et al. Risk of developing diabetes among refugees and immigrants: a longitudinal analysis. J Community Health. 2016;41: 1274–1281. doi: 10.1007/s10900-016-0216-4 27363825
27. Mirza M, Luna R, Mathews B, Hasnain R, Hebert E, Niebauer A, et al. Barriers to healthcare access among refugees with disabilities and chronic health conditions resettled in the US Midwest. J Immigr Minor Health. 2014;16(4):733–742. doi: 10.1007/s10903-013-9906-5 24052476
28. Morris MD, Popper ST, Rodwell TC, Brodine SK, Brouwer KC. Healthcare barriers of refugees post-resettlement. J Community Health. 2009;34:529–38. doi: 10.1007/s10900-009-9175-3 19705264
29. Al-Badri HJA, Khaleefah Ali MA, Ali AA, Sahib AJ. Socio-economic determinants of smoking among Iraqi adults: Data from Non-Communicable Risk Factor STEPS survey 2015. PLoS ONE. 2017;12:e0184989. doi: 10.1371/journal.pone.0184989 28957349
30. Al Hemiery N, Dabbagh R, Hashim MT, Al-Hasnawi S, Abutiheen A, Abdulghani EA, et al. Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014. Addiction. 2017;112:1470–1479. doi: 10.1111/add.13800 28238214
31. Global Burden of Disease Study. Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016;4:e704–13. doi: 10.1016/S2214-109X(16)30168-1 27568068
32. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. doi: 10.1056/NEJMoa012512 11832527
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 5
- Antibiotika na nachlazení nezabírají! Jak můžeme zpomalit šíření rezistence?
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
Nejčtenější v tomto čísle
- National and regional prevalence of posttraumatic stress disorder in sub-Saharan Africa: A systematic review and meta-analysis
- Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study
- Antibody-based therapies for COVID-19: Can Europe move faster?
- The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study